< Terug naar vorige pagina
Onderzoeker
Robbe Saesen
- Disciplines:Ontdekking en evaluatie van biomarkers, Ontdekking en evaluatie van geneesmiddelen, Medicinale producten, Farmaceutica, Farmacognosie en fytochemie, Farmacologie, Farmacotherapie, Toxicologie en toxinologie, Andere farmaceutische wetenschappen
Affiliaties
- Klinische Farmacologie en Farmacotherapie (Afdeling)
Lid
Vanaf10 okt 2018 → Heden
Projecten
1 - 1 of 1
- Evenwicht vinden tussen innovatie en optimalisatie in de oncologie: mogelijkheden voor het overbruggen van de kloof in klinisch kankeronderzoekVanaf10 okt 2018 → 12 sep 2023Financiering: Eigen Middelen zoals patrimonium, inschrijvingsgelden, giften, ....
Publicaties
1 - 10 van 16
- Balancing Innovation With Optimization in Oncology: Avenues for Bridging the Cancer Clinical Research Gap(2023)
Auteurs: Robbe Saesen, Isabelle Huys
- Analysis of the characteristics and the degree of pragmatism exhibited by pragmatic-labelled trials of antineoplastic treatments(2023)
Auteurs: Robbe Saesen, Isabelle Huys
- Defining the role of real-world data in cancer clinical research: The position of the European Organisation for Research and Treatment of Cancer(2023)
Auteurs: Robbe Saesen
Pagina's: 52 - 61 - Involvement of the European Medicines Agency in multi-stakeholder regulatory science research projects: experiences of staff members and project coordinators(2023)
Auteurs: Robbe Saesen
- Real-world data in oncology: a questionnaire-based analysis of the academic research landscape examining the policies and experiences of the cancer cooperative groups(2023)
Auteurs: Robbe Saesen, Isabelle Huys
Pagina's: 1 - 10 - How to balance valuable innovation with affordable access to medicines in Belgium?(2022)
Auteurs: Steven Simoens, Khadidja Abdallah, Liese Barbier, Teresa Barcina Lacosta, Alessandra Blonda, Elif Car, Evelien De Sutter, Rosanne Janssens, Teodora Lalova-Spinks, Robbe Saesen, et al.
- How do cancer clinicians perceive real-world data and the evidence derived therefrom? Findings from an international survey of the European Organisation for Research and Treatment of Cancer(2022)
Auteurs: Robbe Saesen, Isabelle Huys
- Advancing academia-driven treatment optimisation in oncology: Launch of the EMA Cancer Medicines Forum(2022)
Auteurs: Robbe Saesen
Pagina's: 77 - 79 - Characteristics of Early Phase Clinical Trials for Rare Cancers: Insights From Interviews With Stakeholders(2022)
Auteurs: Robbe Saesen, Isabelle Huys
- Accelerating regulatory approval of anticancer therapies: Benefits, drawbacks and recommendations for a more sustainable approach(2021)
Auteurs: Robbe Saesen, Isabelle Huys